Tranexamic Acid
Exacyl contains the active substance tranexamic acid. Tranexamic acid belongs to a group of
medicines called antifibrinolytics. The action of tranexamic acid is to inhibit the fibrinolytic activity of plasmin.
Exacyl is used in:
Before starting treatment with Exacyl, discuss it with your doctor or pharmacist:
You should immediately inform your doctor if you experience any of the following symptoms:
unusual leg pain, muscle weakness, chest pain, irregular pulse, sudden shortness of breath, loss of consciousness, disorientation, severe headache, dizziness, visual disturbances, slowed speech or loss of speech.
Tell your doctor or pharmacist about all medicines you are taking now or have recently taken, as well as any medicines you plan to take, including those available without a prescription.
In particular, inform your doctor if you are taking:
You should also inform your doctor if you are taking:
Exacyl can be taken with or without food.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, ask your doctor or pharmacist for advice before taking this medicine.
Avoid taking this medicine during pregnancy.
Tranexamic acid passes into breast milk. Breastfeeding is not recommended during treatment with this medicine.
During treatment with Exacyl, dizziness and malaise may occur. If you experience such symptoms, do not drive or operate machinery.
This medicine contains a maximum of 4.9 mg of alcohol (ethanol) per ml, which is equivalent to 0.62% by volume. The amount of alcohol in 20 ml (the maximum single dose) of this medicine is equivalent to less than 3 ml of beer or 1 ml of wine. The small amount of alcohol in this medicine will not have noticeable effects.
The medicine contains less than 1 mmol (23 mg) of sodium per dose, which means that the medicine is considered "sodium-free".
Take this medicine always as directed by your doctor or pharmacist. If you are unsure, ask your doctor or pharmacist.
The recommended dose is:
Adults
2 to 4 g per day in 2 or 3 divided doses (i.e., 2 to 4 ampoules per day).
Children
20 mg/kg body weight per day.
The solution should be taken orally.
How to open the ampoules:
![]() | Hold the ampoule in your hand, between your thumb and index finger, as shown. |
![]() | Grasp the end of the ampoule between your thumb and index finger of your other hand. |
![]() | Gently press your thumb on the ring indicating the break point, while providing resistance with your index finger of your other hand. Do not twist. |
![]() | Repeat the entire procedure to open the other end, being careful to hold the open end over a glass. |
Patients with renal impairment
In the case of renal impairment, due to the risk of accumulation of the medicinal product, the dosage of tranexamic acid should be reduced according to the serum creatinine concentration.
The following dosing schedule applies to EXACYL, solution for injection, and should only be used for the solution for injection.
If the serum creatinine concentration is:
between 120 and 250 μmol/l, the dose of tranexamic acid is 10 mg/kg body weight intravenously, twice a day;
between 250 and 500 μmol/l, the dose of tranexamic acid is 10 mg/kg body weight intravenously, once a day (every 24 hours);
above 500 μmol/l, the dose of tranexamic acid is 5 mg/kg body weight intravenously, once a day (every 24 hours).
In the event of an overdose, the following may occur: dizziness of central origin, headache, hypotension, and seizures. Seizures tend to occur more frequently with increasing doses. If you have taken more than the recommended dose of Exacyl, seek medical attention immediately.
If you miss a dose, take it as soon as possible, unless it is almost time for your next dose.
Do not take a double dose to make up for a missed dose.
If you have any further questions about taking this medicine, ask your doctor or pharmacist.
4.
Like all medicines, Exacyl can cause side effects, although not everybody gets them.
During treatment with Exacyl, the following side effects have been observed:
Common(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Frequency not known(frequency cannot be estimated from the available data):
If you experience any side effects, including those not listed in this leaflet, please inform your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Al. Jerozolimskie 181 C, 02-222 Warsaw, Tel.: + 48 22 49 21 301, Fax: + 48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder or its representative in Poland.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Store in a temperature below 25°C, protected from light.
Do not use this medicine after the expiry date stated on the carton. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Ampoules placed in a cardboard box.
The pack contains 5 ampoules of 10 ml each.
CHEPLAPHARM Arzneimittel GmbH
Ziegelhof 24
17489 Greifswald
Germany
Unither Liquid Manufacturing
1-3 Alèe de la Neste
ZI d’en Sigal
31770 Colomiers, France
Cooperation Pharmaceutique Francaise
Place Lucien Auvert
77020 Melun, France
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.